Veon (VEON) Operating Expenses (2009 - 2026)

Veon has reported Operating Expenses for 17 years, with the latest figure at -$533.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses fell 16.38% year-over-year to -$533.0 million; the trailing twelve-month figure through Mar 2026 stood at -$1.5 billion (down 7.78% YoY), and the FY2025 full-year result was $2.5 billion, up 5.71% from the prior year.
• Operating Expenses for Q1 2026 stood at -$533.0 million, down from -$464.0 million in the prior quarter.
• The five-year high for Operating Expenses was -$373.0 million in Q2 2022, with the low at -$777.0 million in Q4 2022.
• Historically, Operating Expenses has averaged -$486.0 million across 5 years, with a median of -$452.0 million in 2024.
• The largest YoY upside for Operating Expenses was 40.42% in 2022 against a maximum downside of 123.01% in 2022.
• Veon's Operating Expenses stood at -$777.0 million in 2022, then soared by 49.68% to -$391.0 million in 2023, then slipped by 14.07% to -$446.0 million in 2024, then retreated by 4.04% to -$464.0 million in 2025, then declined by 14.87% to -$533.0 million in 2026.
• The last three Operating Expenses figures came in at -$533.0 million (Q1 2026), -$464.0 million (Q2 2025), and -$458.0 million (Q1 2025), per Business Quant data.